Latest Leukemia News
February 22nd, 2008 Posted in Cancer Research Notes
Imatinib Effective Over Long Term in Refractory Leukemia
Imatinib mesylate (Gleevec®) therapy shows lasting safety and efficacy in chronic-phase chronic myeloid leukemia patients in whom interferon-alpha treatment has failed.
Taken from LeukemiaLinks, your monthly source of leukemia news, research updates, clinical trials and events sponsored by The Leukemia & Lymphoma Society (LLS). For even more information, regularly visit their Patient Services and Disease Information Web sections.
Friends of Heroes is a national Light the Night Friends and Family team. We are comprised of moms, dads, families and friends compelled to help find a cure for blood cancers.






